Eastpharma Ltd GDR (LSE:EAST) - Overview

Stock Report

Eastpharma Ltd EAST

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap169.10Mil
52-Wk Range-
Yield %-
ISINUS27778Q2049
Volume-
P/E-
P/S-
P/CF-

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
Eastpharma Ltd0.00 
FTSE 100 TR GBP1.54
 
Financials
201320142015
More ...
Income Statement
Turnover217.13210.53209.89
Operating Profit14.4738.3449.39
Net Profit1.06-1.5511.32
Reported EPS-1.00-2.0013.00
Balance Sheet
Current Assets199.37187.81170.36
Non Current Assets324.18323.19282.68
Total Assets523.55511.00453.05
Current Liabilities110.61116.50161.35
Total Liabilities205.24210.89187.72
Total Equity318.32300.11265.33
Cash Flow
Operating Cash Flow30.4818.4733.19
Net Change in Cash18.03-9.59-8.71
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

Eastpharma Ltd is a pharmaceutical company engaged in manufacturing and marketing of branded and in-licensed generic pharmaceuticals in Turkey and other regional. It offers products including Azitro, Farlutal, Pantenol, Vi-Mineral, Amoklavin, and Madopar.
 

Sector

Drug Manufacturers - Major

Market Position

of Companies

Index

Outlook

(09/03/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0013.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE13.80206.9680.66
Op Mrgn8.01-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chairman & Chief Executive Off (intm)Philipp Haas
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.